4.6 Article

Vasodilator Stress Perfusion CMR Imaging Is Feasible and Prognostic in Obese Patients

期刊

JACC-CARDIOVASCULAR IMAGING
卷 7, 期 5, 页码 462-472

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2013.11.011

关键词

cardiac magnetic resonance; obesity; stress testing

资金

  1. American Heart Association Post-Doctoral Fellowship Award [11POST000002]
  2. Heart Failure National Institutes of Health Clinical Research Network [U01-HL084877]
  3. Clinical Fellowship Award from the Alberta Heritage Foundation for Medical Research
  4. National Institutes of Health grant [RO1-HL091157]
  5. Astellas Pharma US

向作者/读者索取更多资源

OBJECTIVES This study sought to determine feasibility and prognostic performance of stress cardiac magnetic resonance (CMR) in obese patients (body mass index [BMI] >= kg/m(2)). BACKGROUND Current stress imaging methods remain limited in obese patients. Given the impact of the obesity epidemic on cardiovascular disease, alternative methods to effectively risk stratify obese patients are needed. METHODS Consecutive patients with a BMI >= 30 kg/m(2) referred for vasodilating stress CMR were followed for major adverse cardiovascular events (MACE), defined as cardiac death or nonfatal myocardial infarction. Univariable and multivariable Cox regressions for MACE were performed to determine the prognostic association of inducible ischemia or late gadolinium enhancement (LGE) by CMR beyond traditional clinical risk indexes. RESULTS Of 285 obese patients, 272 (95%) completed the CMR protocol, and among these, 255 (94%) achieved diagnostic imaging quality. Mean BMI was 35.4 +/- 4.8 kg/m(2), with a maximum weight of 200 kg. Reasons for failure to complete CMR included claustrophobia (n = 4), intolerance to stress agent (n = 4), poor gating (n = 4), and declining participation (n = 1). Sedation was required in 19 patients (7%; 2 patients with intravenous sedation). Sixteen patients required scanning by a 70-cm bore system (6%). Patients without inducible ischemia or LGE experienced a substantially lower annual rate of MACE (0.3% vs. 6.3% for those with ischemia and 6.7% for those with ischennia and LGE). Median follow-up of the cohort was 2.1 years. In a multivariable stepwise Cox regression including clinical characteristics and CMR indexes, inducible ischemia (hazard ratio 7.5; 95% confidence interval: 2.0 to 28.0; p = 0.002) remained independently associated with MACE. When patients with early coronary revascularization (within 90 days of CMR) were censored on the day of revascularization, both presence of inducible ischemia and ischemia extent per segment maintained a strong association with MACE. CONCLUSIONS Stress CMR is feasible and effective in prognosticating obese patients, with a very low negative event rate in patients without ischemia or infarction. (c) 2014 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Correction Cardiac & Cardiovascular Systems

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging (vol 27, pg 659, 2020)

Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W. J. M. Glaudemans, Mazen A. Hanna, Bouke P. C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Mathew S. Maurer, Giampaolo Merlini, Edward J. Miller, James C. Moon, Venkatesh L. Murthy, C. Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H. J. A. Slart, Hein J. Verberne, Jamieson M. Bourque

JOURNAL OF CARDIAC FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Prognostic Value of Stress Cardiac Magnetic Resonance in Patients With Known Coronary Artery Disease

Panagiotis Antiochos, Yin Ge, Bobak Heydari, Kevin Steel, Scott Bingham, Shuaib M. Abdullah, J. Ronald Mikolich, Andrew E. Arai, Patricia Bandettini, Amit R. Patel, Afshin Farzaneh-Far, John F. Heitner, Chetan Shenoy, Steve W. Leung, Jorge A. Gonzalez, Dipan J. Shah, Subha Raman, Victor A. Ferrari, Jeanette Schulz-Menger, Matthias Stuber, Orlando P. Simonetti, Raymond Y. Kwong

Summary: Stress CMR-assessed ischemia was strongly associated with MI/CV death and reclassified patient risk beyond CV risk factors, especially in those considered to be at intermediate risk. Absence of ischemia was associated with a <2% annual rate of MI/CV death.

JACC-CARDIOVASCULAR IMAGING (2022)

Article Cardiac & Cardiovascular Systems

Prognostic Value of T1 Mapping and Feature Tracking by Cardiac Magnetic Resonance in Patients With Signs and Symptoms Suspecting Heart Failure and No Clinical Evidence of Coronary Artery Disease

Ayako Seno, Panagiotis Antiochos, Helena Lichtenfeld, Eva Rickers, Iqra Qamar, Yin Ge, Ron Blankstein, Michael Steigner, Ayaz Aghayev, Michael Jerosch-Herold, Raymond Y. Kwong

Summary: Recent research has found that the assessment of extracellular volume fraction (ECV) and global longitudinal strain (GLS) by cardiac magnetic resonance can provide valuable prognostic information for predicting all-cause death or heart failure hospitalizations in patients suspected of heart failure. This incremental prognostic value of ECV and GLS goes beyond traditional markers such as left ventricular ejection fraction (LVEF) and late gadolinium enhancement (LGE). Additionally, the joint assessment of GLS and ECV has been shown to significantly improve model discrimination and risk reclassification for adverse outcomes in this patient population.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Letter Endocrinology & Metabolism

Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial

Ikaro Breder, Vaneza Lira W. Wolf, Alexandre A. S. Soares, Luiz Sergio F. de Carvalho, Sheila T. Kimura-Medorima, Riobaldo M. Cintra, Joaquim Barreto, Daniel B. Munhoz, Jessica S. Cunha, Isabella Bonilha, Otavio R. Coelho-Filho, Thiago Quinaglia, Wilson Nadruz, Gil Guerra-Junior, Elza Muscelli, Andrei C. Sposito

DIABETES & METABOLISM (2022)

Editorial Material Cardiac & Cardiovascular Systems

Quantitative CMR Perfusion in Patients After CABG br Emerging and Promising Evidence

Raymond Y. Kwong, Rhanderson Cardoso, Michael Jerosch-Herold

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial

Andrei C. Sposito, Ikaro Breder, Joaquim Barreto, Jessica Breder, Isabella Bonilha, Marcus Lima, Alessandra Oliveira, Vaneza Wolf, Beatriz Luchiari, Helison R. do Carmo, Daniel Munhoz, Daniela Oliveira, Otavio R. Coelho-Filho, Otavio R. Coelho, Jose Roberto Matos-Souza, Filipe A. Moura, Luiz Sergio F. de Carvalho, Wilson Nadruz, Thiago Quinaglia, Sheila T. Kimura-Medorima

Summary: The addition of evolocumab to empagliflozin in individuals with T2D improves endothelial function, leading to better vascular function.

CARDIOVASCULAR DIABETOLOGY (2022)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Cardiac MRI T1 and T2 Mapping: A New Crystal Ball?

Michael Jerosch-Herold, Otavio Coelho-Filho

RADIOLOGY (2022)

Editorial Material Cardiac & Cardiovascular Systems

Artificial Intelligence to Extract Endogenous Tissue Characteristics: Has the Future Free From Gadolinium Contrast Arrived?

Raymond Y. Kwong, Michael Jerosch-Herold

CIRCULATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina

Toral R. Y. Patel, Todd Villines, Christopher M. Kramer

EUROPEAN HEART JOURNAL (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

The Role and Advantages of Cardiac Magnetic Resonance in the Diagnosis of Myocardial Ischemia

Thiago Quinaglia A. C. Silva, Theo Pezel, Michael Jerosch-Herold, Otavio R. Coelho-Filho

Summary: Despite advances in noninvasive detection techniques, cardiac magnetic resonance (CMR) remains a valuable tool for the diagnosis of ischemic heart disease. CMR combines multiple capabilities including assessment of wall motion abnormalities, myocardial perfusion imaging, and detection of fibrosis markers. It is well tolerated, safe, and can provide prognosis for cardiovascular events. According to the 2019 ESC guidelines, stress CMR is recommended for the diagnosis of symptomatic coronary artery disease.

JOURNAL OF THORACIC IMAGING (2023)

Article Cardiac & Cardiovascular Systems

Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID-19: A Meta-Analysis

Michael Jerosch-Herold, Carsten Rickers, Steffen E. E. Petersen, Otavio R. Coelho-Filho

Summary: This study found that biological factors can moderate cardiac magnetic resonance myocardial tissue markers in cohorts recovering from COVID-19 infection. The %Delta of native T-1 and T-2 between COVID-19 and control groups showed lower interstudy heterogeneity compared to native T-1 and T-2. Factors such as recovery duration, cardiac troponins, C-reactive protein, and age can moderate the %Delta of T-1 and/or T-2.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Review Cardiac & Cardiovascular Systems

Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases

Dominik C. Benz, Christoph Grani, Panagiotis Antiochos, Bobak Heydari, Mark Colin Gissler, Yin Ge, Sarah A. M. Cuddy, Sharmila Dorbala, Raymond Y. Kwong

Summary: Cardiac magnetic resonance offers multiple facets in the diagnosis, risk stratification, and management of patients with myocardial diseases. Particularly, its feature to precisely monitor disease activity lends itself to quantify response to novel therapeutics.

EUROPEAN HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Noninvasive Multimodality Imaging for the Assessment of Anomalous Coronary Artery

Christoph Grani, Marius R. Bigler, Raymond Y. Kwong

Summary: The purpose of this review is to evaluate how noninvasive comprehensive anatomic- and physiologic evaluation can guide patient management for anomalous aortic origin of a coronary artery (AAOCA). The review explores the role of noninvasive multimodality imaging in characterizing AAOCA, with a focus on the pathophysiology of myocardial ischemia and stress testing protocols.

CURRENT CARDIOLOGY REPORTS (2023)

Review Cardiac & Cardiovascular Systems

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines

Andrew E. Arai, Raymond Y. Kwong, Michael Salerno, John P. Greenwood, Chiara Bucciarelli-Ducci

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2022)

Article Cardiac & Cardiovascular Systems

Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease

Ankur Pandya, Yuan-Jui Yu, Yin Ge, Eike Nagel, Raymond Y. Kwong, Rafidah Abu Bakar, John D. Grizzard, Alexander E. Merkler, Ntobeko Ntusi, Steffen E. Petersen, Nina Rashedi, Juerg Schwitter, Joseph B. Selvanayagam, James A. White, James Carr, Subha V. Raman, Orlando P. Simonetti, Chiara Bucciarelli-Ducci, Lilia M. Sierra-Galan, Victor A. Ferrari, Mona Bhatia, Sebastian Kelle

Summary: Based on the research, cardiovascular magnetic resonance (CMR) is usually a cost-effective option compared to relevant comparators for assessing significant coronary artery disease. The findings suggest that CMR can provide both health benefits and cost savings, making it a favorable choice for evaluating CAD.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2022)

暂无数据